Status:

COMPLETED

Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

URC-CIC Paris Descartes Necker Cochin

Conditions:

Prolonged Pregnancy

Nulliparity

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this trial is to determine whether cervical ripening with isosorbide mononitrate reduce caesarean section in women with post term pregnancies.

Detailed Description

The purpose of this trial is to determine whether cervical ripening with 40 mg of isosorbide mononitrate given intravaginally at 41+0, 41+2 and 41+4 weeks reduce cesarean section in nullipara with pos...

Eligibility Criteria

Inclusion

  • Inclusion criteria :
  • Age \> or = 18 years old
  • TAS \> or = 95 mmHg
  • Singleton
  • Nulliparity
  • Term \> or = 41 weeks + 0 day
  • Bishop score \< or = 5
  • Vertex presentation
  • Intact membranes
  • No contra-indications of the study treatment
  • No maternal or fetal diseases which could indicate immediate labor induction
  • Written informed consent
  • Exclusion criteria :
  • Multiple pregnancy
  • Multiparity
  • Term \< 41 weeks
  • Bishop score \> 5
  • Breech presentation
  • Rupture of the membranes
  • Previous cesarean
  • Indication to immediate labor induction
  • Contraindications to isosorbide mononitrate
  • No co-administration of antihypertensive drugs
  • No social security

Exclusion

    Key Trial Info

    Start Date :

    June 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2014

    Estimated Enrollment :

    1409 Patients enrolled

    Trial Details

    Trial ID

    NCT00930618

    Start Date

    June 1 2009

    End Date

    April 1 2014

    Last Update

    December 1 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Robert Debré Hospital

    Paris, France, 75019